Introduction
The Canadian Pharmaceutical Manufacturers and Exporters Association ("CPMEA") is at the forefront of advocating for Canada's pharmaceutical manufacturers and exporters. Representing the largest manufacturers of medicines in the country, CPMEA aims to build a resilient domestic pharmaceutical manufacturing sector while emphasizing the significance of Canadian-based production in ensuring public health resilience and national security of supply.
Addressing Domestic Needs
The challenges faced by local producers often differ from those affecting importers, making it essential to have an organization that caters specifically to the needs of Canadian manufacturers. Unfortunately, there has been a lack of representation for these producers, resulting in their unique challenges being poorly understood by all levels of government.
Recognizing the need for collaboration, CPMEA offers a platform to engage with stakeholders in finding innovative solutions that will drive a healthy future for the pharmaceutical manufacturing sector in Canada.
Securing the Future
The pharmaceutical manufacturing industry is a vital contributor to Canada's economy, productivity, exports, and security of access to medicines. Recent disruptions and shortages in the supply chain, particularly during the COVID-19 pandemic, have shed light on the vulnerability of relying heavily on external sources of supply.
The overreliance on foreign and geographically concentrated sources for critical drugs and active pharmaceutical ingredients (API) poses a significant national security risk. This realization has prompted other countries to take steps in attracting and supporting local production. Likewise, policy makers in Canada are now recognizing the necessity of engaging with producers in an effort to address these concerns.
Our Vision
CPMEA envisions a united front, with all stakeholders working together to build a robust future for the domestic pharmaceutical manufacturing sector. By bringing producers, policy makers, and industry experts to the table, CPMEA aims to create a collective voice that advocates for innovative policies supporting the continued growth and success of Canada's pharmaceutical manufacturing industry.
Conclusion
As the voice of Canada's pharmaceutical producers and exporters, the Canadian Pharmaceutical Manufacturers and Exporters Association (CPMEA) plays a pivotal role in advocating for the needs of domestic producers. By addressing the unique challenges faced by Canadian manufacturers, CPMEA seeks to foster a better understanding and promote policies that ensure a strong and resilient pharmaceutical manufacturing sector.
Through collaboration and engagement, CPMEA aims to strengthen Canada's position in the global pharmaceutical industry, contributing to the economy, productivity, exports, and most importantly, the health and well-being of all Canadians. Together, we can build a future where local production and access to essential medicines are not only secure but also synonymous with the Canadian identity.
The Canadian Pharmaceutical Manufacturers and Exporters Alliance (CPMEA) – Alliance fabricants et exportateurs pharmaceutiques du Canada (AFEPC) represents pharmaceutical companies that manufacture in Canada. We have come together in an Alliance to tell the story of drug production in Canada and to raise awareness of the unique issues facing our industry.
Click here to contact us, or email us directly at info@cpmea.ca.